Deep Blue Biotech's Eco-Friendly Biomanufacturing
This is a U.K. news story, published by TechCrunch, that relates primarily to Deep Blue Biotech news.
U.K. news
For more U.K. news, you can click here:
more U.K. newsDeep Blue Biotech news
For more Deep Blue Biotech news, you can click here:
more Deep Blue Biotech newsenvironmental science news
For more environmental science news, you can click here:
more environmental science newsTechCrunch news
For more news from TechCrunch, you can click here:
more news from TechCrunchAbout the Otherweb
Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best science news, business news, entertainment news, and much more. If you like environmental science news, you might also like this article about
Deep Blue Biotech. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest biotech startup news, biofuels news, environmental science news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
photosynthetic biomanufacturingTechCrunch
•From pond scum to premium skincare? Deep Blue Biotech is all in on blue-green algae to make better chemicals | TechCrunch
79% Informative
U.K. startup Deep Blue Biotech is building a business around a photosynthesis-based form of biomanufacturing that will enable it to manufacture chemicals in a more environmentally friendly way than conventional production methods.
The startup claims its method can achieve cost parity with conventional chemical production since the genetically engineered microorganism it’s using to produce the chemicals only requires feeding with relatively cheap ingredients: light, water and CO2.
Deep Blue Biotech is announcing an $ 800,000 pre-seed round to keep building towards a commercial MVP .
The round was led by Sustainable Ventures , with participation from One Planet Capital , PCSI , and SFC Capital .
The funding will be used to kick off their first paid pilots, entering into joint development agreements with customers to incorporate their hyaluronic acid into their own products.
VR Score
72
Informative language
66
Neutral language
53
Article tone
informal
Language
English
Language complexity
62
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
long-living
External references
6
Source diversity
6
Affiliate links
no affiliate links